Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$706.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 14 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 15 most recent Form 4 transactions.
| May 16 | BBIO | BridgeBio Pharma, Inc. | FTAX | 4,714 | $66.13 | $311.7K | -3.5% | Open the original filing on SEC.gov |
| Apr 30 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,000 | $71.58 | $143.2K | -1.5% | Open the original filing on SEC.gov |
| Mar 18 | BBIO | BridgeBio Pharma, Inc. | AGRANT | 14,170 | — | — | +11.6% | Open the original filing on SEC.gov |
| Feb 26 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,000 | $66.00 | $132K | -1.6% | Open the original filing on SEC.gov |
| Feb 17 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 510 | $74.31 | $37.9K | -0.4% | Open the original filing on SEC.gov |
| Feb 16 | BBIO | BridgeBio Pharma, Inc. | FTAX◷ | 4,349 | $75.25 | $327.3K | -3.4% | Open the original filing on SEC.gov |
| Dec 12, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 2,003 | $75.15 | $150.5K | -1.5% | Open the original filing on SEC.gov |
| Dec 8, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL◷ | 2,000 | $74.26 | $148.5K | -1.5% | Open the original filing on SEC.gov |
| Nov 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 4,781 | $66.39 | $317.4K | -3.5% | Open the original filing on SEC.gov |
| Aug 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 4,781 | $51.32 | $245.4K | -3.4% | Open the original filing on SEC.gov |
| Aug 7, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 1,000 | $45.44 | $45.4K | -0.7% | Open the original filing on SEC.gov |
| May 16, 2025 | BBIO | BridgeBio Pharma, Inc. | FTAX | 4,780 | $33.84 | $161.8K | -3.2% | Open the original filing on SEC.gov |
| May 2, 2025 | BBIO | BridgeBio Pharma, Inc. | SSELL | 1,026 | $38.51 | $39.5K | -0.7% | Open the original filing on SEC.gov |